Gene expression profiling of gastric cancer

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 15, 2014, Pages 2109-2115

  Jiang, H B ^a   Yang, T J ^a   Lu, P ^a   Ma, Y J ^a  

^a People's Hospital of Zhengzhou   (China)

Author keywords

Gastric cancer; Gene expression; Gene ontology; MiRNAs; Pathway; Transcription factors

Indexed keywords

BRCA1 PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; KRUPPEL LIKE FACTOR 5; MICRORNA; MICRORNA 29B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR FOXP2; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2; TRANSCRIPTION FACTOR YY1; TRANSCRIPTOME;

ARTICLE; BIOLOGICAL FUNCTIONS; CELL CYCLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ONTOLOGY; GENE TARGETING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; PROCEDURES; STOMACH TUMOR;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84921480472     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pelucchi C, Lunet N, Boccia S, Zhang Zf, Praud D, Boffetta P, Levi F, Matsuo K, Ito H, Hu J, Johnson Kc, Ferraroni M, Yu Gp, Peleteiro B, Malekzadeh R, Derakhshan Mh, Ye W, Zaridze D, Maximovitch D, Aragones N, Martin V, Pakseresht M, Pourfarzi F, Bellavia A, Orsini N, Wolk A, Mu L, Arzani D, Kurtz Rc, Lagiou P, Trichopoulos D, Muscat J, La Vecchia C, Negri E. The Stomach Cancer Pooling (Stop) Project: Study Design And Presentation. Eur J Cancer Prev 2014 Feb 20. [Epub Ahead Of Print].
2. Herszenyi L, Tulassay Z. Epidemiology Of Gastrointestinal And Liver Tumors. Eur Rev Med Pharmacol Sci 2010; 14: 249-258.
3. Eftang Ll, Esbensen Y, Tannaes Tm, Blom Gp, Bukholm Ir, Bukholm G. Up-Regulation Of Cldn1 In Gastric Cancer Is Correlated With Reduced Survival. Bmc Cancer 2013; 13: 586.
4. Pasini Fs, Zilberstein B, Snitcovsky I, Roela Ra, Mangone Fr, Ribeiro U, Jr., Nonogaki S, Brito Gc, Cal Legari Gd, Cecconello I, Alves Va, Eluf-Neto J, Chammas R, Federico Mh. A Gene Expression Profile Related To Immune Dampening In The Tumor Microenvironment Is Associated With Poor Prognosis In Gastric Adenocarcinoma. J Gastroenterol 2013; Nov 12. [Epub Ahead Of Print].
5. Wang G, Hu N, Yang Hh, Wang L, Su H, Wang C, Clifford R, Dawsey Em, Li Jm, Ding T, Han Xy, Giffen C, Goldstein Am, Taylor Pr, Lee Mp. Comparison Of Global Gene Expression Of Gastric Cardia And Noncardia Cancers From A High-Risk Population In China. Plos One 2013; 8: E63826.
6. Calin Ga, Croce Cm. Microrna Signatures In Human Cancers. Nat Rev Cancer 2006; 6: 857-866.
7. Waldman Sa, Terzic A. Translating Microrna Discovery Into Clinical Biomarkers In Cancer. Jama 2007; 297: 1923-1925.
8. Garzon R, Marcucci G, Croce Cm. Targeting Micrornas In Cancer: Rationale, Strategies And Challenges. Nat Rev Drug Discov 2010; 9: 775-789.
9. Xia J, Guo X, Yan J, Deng K. The Role Of Mir-148A In Gastric Cancer. J Cancer Res Clin Oncol 2014, Mar 23.
10. Zhu Lh, Liu T, Tang H, Tian Rq, Su C, Liu M, Li X. Microrna-23A Promotes The Growth Of Gastric Adenocarcinoma Cell Line Mgc803 And Downregulates Interleukin-6 Receptor. Febs J 2010; 277: 3726-3734.
11. Yin Wz, Li F, Zhang L, Ren Xp, Zhang N, Wen Jf. Down-Regulation Of Microrna-205 Promotes Gastric Cancer Cell Proliferation. Eur Rev Med Pharmacol Sci 2014; 18: 1027-1032.
12. Yu Y, Zhang Yc, Zhang Wz, Shen Ls, Hertzog P, Wilson Tj, Xu Dk. Ets1 As A Marker Of Malignant Potential In Gastric Carcinoma. World J Gastroenterol 2003; 9: 2154-2159.
13. Irizarry Ra, Hobbs B, Collin F, Beazer-Barclay Yd, Antonellis Kj, Scherf U, Speed Tp. Exploration, Normalization, And Summaries Of High Density Oligonucleotide Array Probe Level Data. Biostatistics 2003; 4: 249-264.
14. Benjamini Y, Hochberg Y. Controlling The False Discovery Rate: A Practical And Powerful Approach To Multiple Testing. Journal Of The Royal Statistical Society. Series B (Methodological) 1995; 57: 289-300.
15. Grimson A, Farh Kk, Johnston Wk, Garrett-Engele P, Lim Lp, Bartel Dp. Microrna Targeting Specificity In Mammals: Determinants Beyond Seed Pairing. Mol Cell 2007; 27: 91-105.
16. John B, Enright Aj, Aravin A, Tuschl T, Sander C, Marks Ds. Human Microrna Targets. Plos Biol 2004; 2: E363.
17. Stormo Gd. Dna Binding Sites: Representation And Discovery. Bioinformatics 2000; 16: 16-23.
18. Bartel Dp. Micrornas: Genomics, Biogenesis, Mechanism, And Function. Cell 2004; 116: 281-297.
19. Krupp M, Maass T, Marquardt Ju, Staib F, Bauer T, Konig R, Biesterfeld S, Galle Pr, Tresch A, Teufel A. The Functional Cancer Map: A Systems-Level Synopsis Of Genetic Deregulation In Cancer. Bmc Med Genomics 2011; 4: 53.
20. Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S, Tanaka H. Identification Of Pathogenesis-Related Micrornas In Hepatocellular Carcinoma By Expression Profiling. Oncol Lett 2012; 4: 817-823.
21. Chen L, Li Y, Fu Y, Peng J, Mo Mh, Stamatakos M, Teal Cb, Brem Rf, Stojadinovic A, Grinkemeyer M, Mccaffrey Ta, Man Yg, Fu Sw. Role Of Deregulated Micrornas In Breast Cancer Progression Using Ffpe Tissue. Plos One 2013; 8: E54213.
22. Zhuang M, Gao W, Xu J, Wang P, Shu Y. The Long Non-Coding Rna H19-Derived Mir-675 Modulates Human Gastric Cancer Cell Proliferation By Targeting Tumor Suppressor Runx1. Biochem Biophys Res Commun 2014; 448: 315-322.
23. Shou Zx, Jin X, Zhao Zs. Upregulated Expression Of Adam17 Is A Prognostic Marker For Patients With Gastric Cancer. Ann Surg 2012; 256: 1014-1022.
24. Bonadies N, Pabst T, Mueller Bu. Heterozygous Deletion Of The Pu.1 Locus In Human Aml. Blood 2010; 115: 331-334.
25. Yuki H, Ueno S, Tatetsu H, Niiro H, Iino T, Endo S, Kawano Y, Komohara Y, Takeya M, Hata H, Okada S, Watanabe T, Akashi K, Mitsuya H, Okuno Y. Pu.1 Is A Potent Tumor Suppressor In Classical Hodgkin Lymphoma Cells. Blood 2013; 121: 962-970.
26. Dobrodeev Gv. [Bone Marrow Cellular Makeup In Stomach Cancer].Vopr Onkol 1979; 25: 20-23.
27. Takahashi H, Murai Y, Tsuneyama K, Nomoto K, Okada E, Fujita H, Takano Y. High Labeling Indices Of Cdc25B Is Linked To Progression Of Gastric Cancers And Associated With A Poor Prognosis. Appl Immunohistochem Mol Morphol 2007; 15: 267-272.
28. Eeckhoute J, Carroll Js, Geistlinger Tr, Torresarzayus Mi, Brown M. A Cell-Type-Specific Transcriptional Network Required For Estrogen Regulation Of Cyclin D1 And Cell Cycle Progression In Breast Cancer. Genes Dev 2006; 20: 2513-2526.
29. Loh M, Koh Kx, Yeo Bh, Song Cm, Chia Ks, Zhu F, Yeoh Kg, Hill J, Iacopetta B, Soong R. Meta-Analysis Of Genetic Polymorphisms And Gastric Cancer Risk: Variability In Associations According To Race. Eur J Cancer 2009; 45: 2562-2568.
30. Cayrol C, Lacroix C, Mathe C, Ecochard V, Ceribelli M, Loreau E, Lazar V, Dessen P, Mantovani R, Aguilar L, Girard Jp. The Thap-Zinc Finger Protein Thap1 Regulates Endothelial Cell Proliferation Through Modulation Of Prb/E2F Cell-Cycle Target Genes. Blood 2007; 109: 584-594.
31. Lu C, Li Jy, Ge Z, Zhang L, Zhou Gp. Par-4/Thap1 Complex And Notch3 Competitively Regulated Premrna Splicing Of Ccar1 And Affected Inversely The Survival Of T-Cell Acute Lymphoblastic Leukemia Cells. Oncogene 2013; 32: 5602-5613.
32. He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T. Overexpression Of Sorcin Results In Multidrug Resistance In Gastric Cancer Cells With Up-Regulation Of P-Gp. Oncol Rep 2011; 25: 237-243.